Delivery Order SPE2DB20D2104-SPE2DB23FV53N
Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $739
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $369.42 to Amerisourcebergen Drug Corporation. The order is for 4562101680 QUVIVIQ 50 MG TABLET 30S to be delivered to a location in Conshohocken, Pennsylvania between September 8-11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. The Defense Logistics Agency is the funding agency for this delivery order placed against an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred twenty-three dollars and fourteen cents to Amerisourcebergen Drug Corporation. The order is for 4561770565 QUVIVIQ 50 MG TABLET 30S to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No subcontractors or set aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,712.87 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quviviq 25 mg tablets (30-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately one thousand dollars to Amerisourcebergen Drug Corporation for 25mg Quviviq tablets. Under this order, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, with performance required between September 20th and 21st of 2023. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, this award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred twenty-three thousand one hundred fourteen dollars to Amerisourcebergen Drug Corporation for the supply of fifty milligram Quviviq tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver thirty tablets of the specified medication to a facility in Conshohocken, Pennsylvania between August 11th and 14th, 2023. The Defense Logistics Agency routinely utilizes...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $246.30 to Amerisourcebergen Drug Corporation. The order is for 4562070977 QUVIVIQ 50 MG TABLET 30S to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. The Defense Logistics Agency routinely issues delivery orders against various...
- Amerisourcebergen Drug Corp has been awarded a delivery order against an undisclosed contract vehicle to supply one hundred twenty-three dollars worth of QUVIVIQ 25 MG TABLET 30S to the Defense Logistics Agency. Performance will occur in Conshohocken, Pennsylvania by September 13, 2023. The firm fixed price order was awarded on September 12, 2023 without a set-aside designation. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will serve as the prime contractor...
- The Defense Logistics Agency awarded a $1,115.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Quviviq 50 mg tablets (30-count). The contract, which is scheduled for completion by November 12, 2025, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a $246,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561543638 QUVIVIQ 50 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will fulfill the order from its facility located at the same address. Funding is provided by DLA to support its medical supply needs. No subcontractors or set aside designations were specified. The single day period of performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.56 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's established pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV53NDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $739 to Amerisourcebergen Drug Corporation. The order is for 4562315414, Quviviq 25mg tablets, to be delivered within a single day in September 2023 to a location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will perform as the prime contractor, with parent company Amerisourcebergen Corporation. The delivery order was issued under an existing DLA contract vehicle to supply pharmaceutical products in support of Department of Defense programs. No set aside designations or subcontractors were indicated.
Generated 12/26/23, 9:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $739 | 9/26/23 |